Honma Y, Monden N, Yamazaki K, Kano S, et al. Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU. Clin Cancer Res 2024;30:3416-3427.
PMID: 38940667